There’s “quite big news” around weight loss medications circulating right now, says Wajahat Mehal, MD, director of Yale ...

The Food and Drug Administration has approved the first GLP-1 pill for weight loss and maintenance. Drugmaker Novo Nordisk ...

The Wegovy pill is expected to hit the market in January, joining injectable GLP-1 drugs that have transformed obesity treatment. One form you swallow, the other you inject. What else is different?

The Food and Drug Administration on Monday approved a pill version of the weight-loss injectable drug Wegovy, offering ...

Changes are coming in 2026 for GLP-1 drugs. Long defined by high prices, shortages and weekly injections, drugs including ...

With changing times, the need to remain healthy and fit has become a bigger goal for many people. This goal to lose weight and become healthy is no more far-fetched now. It is something that can be ...

The drugs' high prices, along with spotty insurance coverage, have left them out of reach for many Americans. Read more at ...

A pill version of the popular GLP-1 weight-loss drug Wegovy has been green-lit for use in the U.S. Here’s what that means for ...

Losing weight hasn’t quite been the hardest part of modern obesity treatment. Keeping it off is. That’s exactly the problem Eli Lilly (LLY) seems to have cracked with its weight-loss pill. In a ...

The changing market is forcing the drugmakers to hire people with more consumer-focused expertise, strike more deals with ...

Drugs that treat diabetes and weight loss have become a commercial and cultural phenomenon. But supply shortages and eye-watering prices have kept slimming jabs largely confined to the rich world, ...

The Food and Drug Administration on Monday approved a pill version of Wegovy, Novo Nordisk’s blockbuster weight loss drug.